Astrana Health updates investor presentation with Q1 2026 metrics and FY2026 outlook

Astrana Health, Inc.

Presentation includes G&A efficiency chart with data for FY2023-FY2026E and Q1 2025/Q1 2026.
Revenue mix shown across Medicare, Medicaid, Commercial, and other risk arrangements.
No specific financial guidance changes disclosed; presentation used for conferences.
Company does not undertake to update the presentation content beyond this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.